Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2551–2600 of 34667
appointed Charles W. Newton. to the Board, effective on such date, to fill the resulting vacancy and to serve as a Class III director
On April 28, 2025, the Board adopted a resolution nominating Kelly Campbell for election to the Board with a term that expires at the Company’s 2028 annual meeting of stockholders.
Effective as of the 2025 Annual Meeting, Mr. Cavens will be appointed to fill the vacancy resulting from this increase with a term expiring at the Company’s 2027 annual meeting of stockholders.
On April 28, 2025, Alan Spoon notified the Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) of his decision to not stand for re-election following the expiration of his current term, which will expire at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On April 25, 2025, Virginia Gambale, a member of the board of directors (the “Board”) of Jamf Holding Corp. (the “Company”) and the Audit Committee of the Board, notified the Company of her intention to not stand for re-election at the Company’s upcoming 2025 annual general meeting of shareholders scheduled for June 10, 2025 (the “Annual Meeting”).
In addition, on April 25, 2025, Charles Guan, a member of the Board of the Company, notified the Company of his intention not to stand for re-election at the Annual Meeting.
On April 29, 2025, the Board of Directors (the “Board”) of Exact Sciences Corporation (the “Company”) appointed Leslie Trigg as a Class II member of the Board with a term ending at the Company’s 2026 annual meeting of shareholders.
Ms. Trigg was appointed to fill the vacancy created by the resignation of Kathleen Sebelius (formerly a Class II director) from the Board on April 29, 2025 for her retirement.
On April 26, 2025, R. Keith Woods informed the board of directors (the “Board”) of Rocket Pharmaceuticals, Inc. (the “Company”) that he has accepted a Chief Operating Officer position with a biopharmaceutical company and therefore has decided not to stand for re-election to the Board at the Company’s upcoming 2025 annual meeting (the “2025 Annual Meeting”).
appointed Alan Alperin as a Class I director of the Company, and stockholders of the Company elected Mr. Alperin, effective April 25, 2025
appointed Kym M. Hubbard as a Class II director of the Company, and stockholders of the Company elected Ms. Hubbard, effective April 25, 2025
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
Jonathan Z. Cohen, Edward E. Cohen, William I. Fradin, Eldron Blackwell, A. Kayode Ogunro, Robert W. Karlovich III and Eric T. Litvin (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”)
Jonathan Z. Cohen, Edward E. Cohen, William I. Fradin, Eldron Blackwell, A. Kayode Ogunro, Robert W. Karlovich III and Eric T. Litvin (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”)
Jonathan Z. Cohen, Edward E. Cohen, William I. Fradin, Eldron Blackwell, A. Kayode Ogunro, Robert W. Karlovich III and Eric T. Litvin (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”)
Jonathan Z. Cohen, Edward E. Cohen, William I. Fradin, Eldron Blackwell, A. Kayode Ogunro, Robert W. Karlovich III and Eric T. Litvin (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”)
Jeffrey F. Brotman resigned as a member of the Board.
Jonathan Z. Cohen, Edward E. Cohen, William I. Fradin, Eldron Blackwell, A. Kayode Ogunro, Robert W. Karlovich III and Eric T. Litvin (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”)
Jonathan Z. Cohen, Edward E. Cohen, William I. Fradin, Eldron Blackwell, A. Kayode Ogunro, Robert W. Karlovich III and Eric T. Litvin (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”)
Jonathan Z. Cohen, Edward E. Cohen, William I. Fradin, Eldron Blackwell, A. Kayode Ogunro, Robert W. Karlovich III and Eric T. Litvin (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”)
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
Effective as of the Effective Time, each of Stuart A. Randle, Julian Francis, Major General (Ret.) Barbara G. Fast, Alan Gershenhorn, Melanie M. Hart, Racquel H. Mason, Robert M. McLaughlin, Earl Newsome, Jr., Neil S. Novich and Douglas L. Young ceased to be a member of the Board and all committees thereof.
On April 23, 2025, Peter Wagner notified the Board of Directors (the “Board”) of Cyber App Solutions, Corp. (the “Company”) of his resignation as a member of the Board, effective immediately.
On April 23, 2025, the Board increased its size from five to six members and appointed Mr. Christopher as a Class II director.
On April 28, 2025, Arindam Bose notified the board of directors (the “Board”) of Dyadic International, Inc. (the “Company”) of his decision to retire as a director of the Board, effective at the Company’s annual meeting to be held on June 20, 2025.
The Board then elected Mr. Jason Spittlehouse and Mr. Peter J. Young to the Board of Directors.
The Board then elected Mr. Jason Spittlehouse and Mr. Peter J. Young to the Board of Directors.
On April 28, 2025, the Company appointed Merdad Parsey, M.D., Ph.D, as a member of the Board of Directors (the “Board”) of Ardelyx, Inc., a Delaware corporation (the “Company”), effective immediately
On April 28, 2025, each of Christopher Fowler, Laura Lee, Christopher Petzel, and Carlo Zola notified The Arena Group Holdings, Inc. (the "Company") that they would resign from the Company's board of directors (the "Board") and all committees thereof, effective as of April 28, 2025.
On April 28, 2025, each of Christopher Fowler, Laura Lee, Christopher Petzel, and Carlo Zola notified The Arena Group Holdings, Inc. (the "Company") that they would resign from the Company's board of directors (the "Board") and all committees thereof, effective as of April 28, 2025.
On April 28, 2025, each of Christopher Fowler, Laura Lee, Christopher Petzel, and Carlo Zola notified The Arena Group Holdings, Inc. (the "Company") that they would resign from the Company's board of directors (the "Board") and all committees thereof, effective as of April 28, 2025.
In addition, on April 28, 2025, Lynn Petersmarck was appointed to the Board.
On April 28, 2025, each of Christopher Fowler, Laura Lee, Christopher Petzel, and Carlo Zola notified The Arena Group Holdings, Inc. (the "Company") that they would resign from the Company's board of directors (the "Board") and all committees thereof, effective as of April 28, 2025.
Mr. Kinzer’s resignation from the Board was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On April 25, 2025, following the 2025 annual meeting of stockholders (the “Annual Meeting”) of Life Time Group Holdings, Inc. (the “Company”), the Company’s Board of Directors, upon recommendation of the Nominating and Corporate Governance Committee, appointed Jennifer Pomerantz to the Board of Directors.
On April 22, 2025, Frank G. Heard informed the Board of Directors (the “Board”) of Apogee Enterprises, Inc. (the “Company”) that he intends to retire from the Board and will not stand for re-election at the 2025 Annual Meeting of Shareholders (the “Annual Meeting”), Mr. Heard will continue to serve on the Board until the Annual Meeting.
On April 25, 2025, the Board of Directors (the “Board”) of F5 reviewed and accepted the resignation of Peter Klein from his position as a director of the Company, including his membership on the Audit Committee, effective April 25, 2025.
Also on April 25, 2025, Barbara Shattuck Kohn and Saul Reibstein notified the Board of their respective decision not to stand for reelection to the Board at the expiration of their respective current term at the Company’s 2025 annual meeting of shareholders
Also on April 25, 2025, Barbara Shattuck Kohn and Saul Reibstein notified the Board of their respective decision not to stand for reelection to the Board at the expiration of their respective current term at the Company’s 2025 annual meeting of shareholders
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.